CONTINUATION PAGE: STAY WITHIN MARGINS INDICATED 
BRENNER, Malcolm K. 
Principal Investigator/Program Director (Last, first, middle): 
Furman WL, Fairclough DL, Huhn RD, Pratt CB, Stute N, Petros WP, Evans WE, Bowman LC, 
Douglass ED, Santana VM, Meyer WH, Crist WM. Therapeutic effects and pharmacokinetics 
of recombinant human granulocyte-marcophage colony-stimulating factor in childhood cancer 
patients receiving myelosuppressive chemotherapy. J Clin Oncol 9:1022-1028, 1991. 
Rao BN, Santana VM, Parham D, Pratt CB, Fleming ID, Hudson M, Fontanesi J, Philippe P, 
Schell MJ. Pediatric non rhabdo soft tissue sarcomas: Influence of size, invasiveness 
and grade on outcome. Arch Surg 126:1490-1495, 1991. 
Bowman LC, Hancock ML, Santana VM, Hayes FA, Kun L, Parham DM, Furman WL, Rao BN, Green 
AA, Crist WM. Impact of intensified therapy on clinical outcome in infants and children 
with neuroblastoma. J Clin Oncol 9:1599-1608, 1991. 
Santana VM, et al. A phase I trial of high-dose carboplatin and etoposide with 
autologous marrow support for treatment of stage D neuroblastoma. Human Gene Ther 2:257- 
272, 1991. 
Santana VM, Mirro JJ, Kearns C, Schell MJ, Crom W, Blakley RL. 2-Chlorodeoxyadenosine 
produces a high rate of complete hematologic remission in relapsed acute myeloid 
leukemia. J Clin Oncol 10:287-302, 1992. 
Santana VM, Thompson EB, Bowman LC, Brenner M, Mirro J Jr. Sequential high-dose 
carboplatin and etoposide with autologous marrow support in children with relapsed solid 
tumors. Cancer Res (in press). 
Stute N, Santana VM, Rodman JH, Schell MJ, Evans WE. Pharmacokinetics of subcutaneous 
recombinant human granulocyte colony-stimulating factor in children. Blood 11:2849-2854, 
1992. 
Rivera GK, Pui C-H, Santana VM, Hancock M, Mahmoud H, Sandlund JT, Riberio R, Furman W, 
Marina N, Crist WM. Progress in the treatment of adolescents with acute lymphoblastic 
leukemia. Bone Marrow Transplant (in press). 
Madden T, Sunderland M, Santana VM, Rodman JH. The pharmacokinetics of high-dose 
carboplatin in pediatric cancer patients. Cancer Chemo Pharmacology (in press). 
Sandlund JT, Ribeiro R, Abromowitch M, Ayers D, Santana VM, Berard CW, Hutchison RE, 
Crist WM, Rafferty M, Faircloigh D, Pui C-H. Factors contributing to the prognostic 
significance of bone marrow involvement in chldhood non-Hodgkin lymphoma. Leukemia (in 
press ) . 
Buschle DRR, Foreman NK, Bartholomew C, Moen RC, Santana VM, Ihle JN, Brenner MK. 
Analysis of neuroblastoma relapse after autologous bone marrow transplantation using 
retrovirus mediated gene transfer. Human Gene Therapy (in press). 
Rivera GK, Pui C-H, Hancock ML, Santana VM, Sandlund JT, Hurwitz C, Ribeiro R, Furman W, 
Crist WM. Update of St. Jude study XI for childhood acute lymphoblastic leukemia. (in 
press ) . 
Pappo AS, Etcubanas E, Santana VM, Rao RN, Fontanesi J, Roberson PK, Bowman L, Crist WM, 
Shaprio DN. A phase II trial of ifosfamide in previously untreated children and 
adolescents with unresectable rhabdomyosarcoma. J Clin Oncol (in press). 
PHS 398 (Rev 9 9 1 ) Page 
Number baMamnseculively al the bonom throughout the application Do not use suffixes si{fc©£0£jlbinant DNA Research, Volume 17 
